Full metadata record
| DC Field | Value | Language |
|---|---|---|
| dc.creator | Soria-Juan, B. (Bárbara) | - |
| dc.creator | Escacena, N. (Natalia) | - |
| dc.creator | Capilla-González, V. (Vivian) | - |
| dc.creator | Aguilera, Y. (Yolanda) | - |
| dc.creator | Llanos, L. (Lucía) | - |
| dc.creator | Tejedo, J.R. (Juan R.) | - |
| dc.creator | Bedoya, F.J. (Francisco J.) | - |
| dc.creator | Juan, V. (Verónica) | - |
| dc.creator | Martinez-de-la-Cuesta, A. (Antonio) | - |
| dc.creator | Ruiz-Salmerón, R. (Rafael) | - |
| dc.creator | Andreu, E.J. (Enrique José) | - |
| dc.creator | Grochowicz, L. (Lukasz) | - |
| dc.creator | Prosper-Cardoso, F. (Felipe) | - |
| dc.creator | Sanchez-Guijo, F.M. (Fermín M.) | - |
| dc.creator | Lozano, F.S. (Francisco S.) | - |
| dc.creator | Miralles, M. (Manuel) | - |
| dc.creator | Río-Solá, L. (Lourdes) del | - |
| dc.creator | Castellanos, G. (Gregorio) | - |
| dc.creator | Moraleda, J. M. (José M.) | - |
| dc.creator | Sackstein, R. (Robert) | - |
| dc.creator | García-Arranz, M. (Mariano) | - |
| dc.creator | Garcia-Olmos, D. (Damián) | - |
| dc.creator | Martín, F. (Franz) | - |
| dc.creator | Hmadcha, A. (Abdelkrim) | - |
| dc.creator | Soria, B. (Bernat) | - |
| dc.date.accessioned | 2023-11-23T13:05:30Z | - |
| dc.date.available | 2023-11-23T13:05:30Z | - |
| dc.date.issued | 2020 | - |
| dc.identifier.citation | Soria-Juan, B. (Bárbara); Escacena, N. (Natalia); Capilla-González, V. (Vivian); et al. "Corrigendum: Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus (vol 10, 1151, 2019)". Frontiers in immunology. 11, 2020, 2029 | es |
| dc.identifier.issn | 1664-3224 | - |
| dc.identifier.uri | https://hdl.handle.net/10171/67958 | - |
| dc.description.abstract | Reference 86 was also included as “Escacena N. Cellular medication as a therapeutic alternative in chronic critical limb ischemia in diabetic patients without the possibility of revascularization. Dissertation Thesis. Sevilla Spain: University of Sevilla. (2016)”. This reference should be included as number 107 “Escacena N. Cellular medication as a therapeutic alternative in chronic critical limb ischemia in diabetic patients without the possibility of revascularization (Dissertation Thesis). University of Sevilla, Seville, Spain (2016).” | es_ES |
| dc.language.iso | eng | es_ES |
| dc.publisher | Frontiers Media | es_ES |
| dc.rights | info:eu-repo/semantics/openAccess | es_ES |
| dc.subject | Corrigendum | es_ES |
| dc.subject | Cellular medicaments | es_ES |
| dc.subject | Cell-based therapy | es_ES |
| dc.subject | Clinical trials | es_ES |
| dc.subject | Diabetes | es_ES |
| dc.subject | Critical limb ischemia | es_ES |
| dc.subject | Cost-effectiv | es_ES |
| dc.title | Corrigendum: Cost-effective, safe, and personalized cell therapy for critical limb ischemia in type 2 diabetes mellitus (vol 10, 1151, 2019) | es_ES |
| dc.type | info:eu-repo/semantics/article | es_ES |
| dc.description.note | This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms. | es_ES |
| dc.identifier.doi | 10.3389/fimmu.2020.02029 | - |
| dadun.citation.publicationName | Frontiers in immunology | es_ES |
| dadun.citation.startingPage | 2029 | es_ES |
| dadun.citation.volume | 11 | es_ES |
| dc.identifier.pmid | 32983148 | - |
Files in This Item:
Statistics and impact
Items in Dadun are protected by copyright, with all rights reserved, unless otherwise indicated.
